Biosimilars Approval to Biogenerics in Clinical Practice


 



Biological medicines are much more structurally complex and extremely sensitive to manufacturing conditions and therefore more difficult to characterize and produce than small molecule drugs. Even minor changes in manufacturing may lead to significant variations of the cellular systems used for biological production, as well as to differences in the structure, stability, or other quality aspects of the end product, all of which have the potential to affect tolerability and/or efficacy and increase the risk of immune responses. Owing to these issues, specific regulatory guidance on Biosimilars is continuously evolving, and there is some disagreement on which studies need to be implemented to approve a Biosimilars. According to current literature, the following points on Biosimilars deserve consideration: Biosimilars development is characterized by global harmonization, although several not fully answered questions remain regarding extrapolation of indications, switching or interchange ability, and tolerability; in patients with rheumatic diseases, the tolerability and efficacy of Biosimilars in clinical practice remain to be established; several medical and patient associations have published position papers on Biosimilars requesting that safety, efficacy, and traceability be carefully considered; long-term post marketing studies should be implemented to allow physicians to gain confidence in Biosimilars.



 


    Related Conference of Biosimilars Approval to Biogenerics in Clinical Practice

    May 12-12, 2021

    27th Cognitive Neuroscience Congress

    London, UK
    May 17-17, 2021

    Annual Meet on Pharmacovigilance & Drug Safety

    Tokyo, Japan
    May 17-18, 2021

    8th European Biopharma Congress

    Prague, Czech Republic
    June 07-08, 2021

    2nd European Conference on Pharmacovigilance and Drug Safety

    Prague, Czech Republic
    June 21-22, 2021

    1 st Global Summit on Generic Drugs and Quality Control

    Prague, Czech Republic
    July 06-07, 2021

    14th Global Pharmacovigilance And Clinical Trials Summit

    Albufeira, Portugal
    July 10-11, 2021

    2 nd Pharma Expo China

    Tokyo, Japan
    July 13-14, 2021

    24th Asia Pacific Pharma Congress

    Melbourne,
    July 26-27, 2021

    36th World Pharmacology and Therapeutics Forum

    Paris, France
    July 30-30, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Prague, Czech Republic
    August 16-17, 2021

    Global summit on Cosmetic & Reconstructive Surgery

    Tokyo, Japan
    August 16-17, 2021

    34rd World Congress on Pharmacology

    London, UK
    August 23-24, 2021

    7th World Congress on Medicinal Plants and Marine Drugs

    Prague, Czech Republic
    August 30-31, 2021

    20th Medicinal & PharmaceuticalSciences Congress

    London, UK
    September 13-14, 2021

    3rd World Congress on Drug Discovery and Drug Design

    Tokyo, Japan
    September 17-18, 2021

    9th International Conference on Clinical Trials

    Montreal, Canada
    September 20-21, 2021

    Asia Pacific Pharmaceutics & Drug Delivery Congress

    Tokyo, Japan
    September 27-28, 2021

    2 nd World Pharma Expo

    Tokyo, Japan
    October 05-06, 2021

    International Congress on Drug Delivery

    Auckland, Newzealand
    October 21-22, 2021

    2nd Annual Congress on Antibiotics and Bacterial Infections

    Geneva, Switzerland
    October 29-30, 2021

    14th World Drug Delivery Summit

    Vancouver, Canada
    October 29-30, 2021

    12th Annual Biomarkers and Clinical Research Congress

    Vancouver, Canada
    November 16-17, 2021

    World Congress on Biologics and Biosimilars

    Osaka, Japan
    November 26-27, 2021

    World Biosimilars & Biologics Congress

    Vancouver, Canada
    December 02-03, 2021

    17th Annual Congress on Pharmacology and Toxicology

    Tokyo, Japan
    December 02-03, 2021

    International Conference on Bio Pharmaceutics

    Auckland, Newzealand
    December 07-08, 2021

    2nd International Conference on Biotechnology and Healthcare

    Auckland, Newzealand
    December 15-16, 2021

    12th World Congress on Bioavailability and Bioequivalence

    Bali, Indonesia

    Biosimilars Approval to Biogenerics in Clinical Practice Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in